Abstract:
The present invention discloses a switching amplifier and its modulations process, which belongs to the field of non-filters-type switching amplifier. The switching amplifier comprises: pulse-width modulation with dual comparator, multiple-loop feedback structure, only one integrating amplifier with dual-ends output needed for each loop, no less than two feedback loops set between the integrating amplifier and H-bridge, in addition, no any low-pass filters needed adding to the feedback path. Multiple feedback loops are adopted in the present invention, which can low the distortion of the switching amplifier to the extent. Furthermore, no any extra low-pass filters are needed adding to the feedback path, which making the products a higher cost effectiveness.
Abstract:
The present invention discloses a switching amplifier and its modulations process, which belongs to the field of non-filters-type switching amplifier. The switching amplifier comprises; pulse-width modulation with dual comparator, multiple-loop feedback structure, only one integrating amplifier with dual-ends output needed for each loop, no less than two feedback loops set between the integrating amplifier and H-bridge, in addition, no any low-pass filters needed adding to the feedback path. Multiple feedback loops are adopted in the present invention, which can low the distortion of the switching amplifier to the extent. Furthermore, no any extra low-pass filters are needed adding to the feedback path, which making the products a higher cost effectiveness.
Abstract:
The present invention features a direct, closed-loop method for controlling an unbalanced, power-distribution network having a great number of nodes, branches and laterals, as well as multiphase loads. The network has a radial structure. One or more formulae are first derived for a power-distribution network. The formulae may be an explicit loss formula, a voltage formula, a line flow formula or any combination thereof. Network flow programming techniques which incorporate the formulae are then developed to directly achieve steady state. Finally, the control steps are performed on the power-distribution network in real time to control its operation. The control steps may include placing a capacitor, regulator or switch at a specific position in the network and/or reconfiguring the network in some other manner.
Abstract:
An apparatus for delivering devices. The apparatus comprises a catheter with an elongated shaft having a first lumen and a second lumen extending therethrough. The apparatus further comprises a distal section with a lumen in communication with a port in a distal end of the catheter and with the first lumen and the second lumen. The first lumen is configured for a first device and the second lumen is configured for a second device to be disposed therein. The apparatus further comprises a proximal adapter coupled to the elongated shaft with a first port in communication with the first lumen and a second port in communication with the second lumen.
Abstract:
A drug-delivery system is provided including at least 100 μg of everolimus and clobetasol, such that the ratio of everolimus to clobetasol is at least 10:1 (w/w) or the amount of everolimus by weight is at least 10 times more than clobetasol. The system can be a stent. Also provided a method of treating restenosis or vulnerable plaque of a blood vessel, the method includes locally administering to a patient a first drug selected from a group consisting of rapamycin (sirolimus), Biolimus A9, deforolimus, AP23572, tacrolimus, temsirolimus, pimecrolimus, zotarolimus (ABT-578), 40-O-(2-hydroxy)ethylrapamycin (everolimus), 40-O-(3-hydroxy)propylrapamycin, 40-O-[2-(2-hydroxy)ethoxy]ethylrapamycin, 40-O-tetrazolylrapamycin and 40-epi-(N1-tetrazolyl)rapamycin, and locally administering to a patient a second drug consisting of clobetasol, wherein the minimum amount of the first drug that is locally administered is 100 μg, and wherein the ratio of the first drug to the second drug is, for example, 10:1 to 100:1 (w/w).
Abstract:
A linear actuator implements two contact switches for travel-limit control of an output shaft of the linear actuator and implements a variable resistor that is connected with a reduction gear of a motor of the linear actuator for providing a position feedback function.
Abstract:
A synchronous actuator comprises a telescopic cylinder assembly having at least three pivotally connected cylinders, a drive assembly and a driven assembly. The drive assembly is connected to two adjacent cylinders. The driven assembly is connected to three adjacent cylinders. With the drive assembly and the driven assembly, the cylinders of the telescopic cylinder assembly can be extended or retracted synchronously in axial direction.
Abstract:
A video on demand system for providing graceful degradation and fault tolerance comprises a plurality of media storage ends, a first level network device, and a plurality of video trunk combiners. Each of the media storage ends respectively stores a plurality of video files, and provides a plurality of frequency channels to transmit the video files. The first level network device receives each of the frequency channels provided by each of the media storage ends, and externally transmits at least one of the frequency channels provided by at least two of the media storage ends. Each of the video trunk combiners is connected between the first level network device and at least one user end, and receives the at least one of the frequency channels provided by at least two of the media storage ends via the first level network device.
Abstract:
The present invention is directed to implantable devices (e.g., drug-delivery stents) containing nuclear receptor ligands. The nuclear receptor ligands may be, inter alia, PPAR ligands or retinoids. The invention also provides for a method of treating or preventing vascular disorders (e.g., restenosis) and related disorders using the nuclear receptor ligand-containing devices.